With strong support from public shareholders, Cannasouth Limited successfully completed an Initial Public Offer (IPO) and listed on the New Zealand Main Board (NZX) on 19 June 2019 with the ticker code CBD.  The IPO was oversubscribed, and the Company raised the full amount of $10 million from the public.

For investors interested in purchasing Cannasouth (CBD) shares, click here for a full list of NZX participants who are accredited by NZX to advise on NZX markets.

The 2021 Annual Shareholder Meeting was held at the offices of Link Market Services, on Monday, 28 June 2021.

A link to the presentation slides is available here, and the CEO commentary is available here.

Cannasouth Limited released a Medicinal Cannabis Industry Update in June 2021.

This update is designed to share information about the emerging medicinal cannabis industry both in New Zealand and globally; the opportunities and challenges facing industry players, the New Zealand regulatory environment, and the barriers to entry.

The PDF is available to view and download at the following link:
The New Zealand and Global Medicinal Cannabis Industry Update.

A short overview of Cannasouth’s history, milestones, and management team.

Cannasouth Fact Sheet

In September, in lieu of an Investor Roadshow in 2020, Cannasouth invited investors and website subscribers to submit questions about anything related to the business.
Cannasouth’s creative team worked with in-house experts to answer the questions in a series of videos.